<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04985071</url>
  </required_header>
  <id_info>
    <org_study_id>VTrQuoc</org_study_id>
    <nct_id>NCT04985071</nct_id>
  </id_info>
  <brief_title>Complication of Pancreatic Fistula and Bleeding After Pancreaticoduodenectomy in Treatment Periampullary Cancer</brief_title>
  <acronym>PF</acronym>
  <official_title>Study of Pancreatic Fistula and Bleeding Complication After Pancreaticoduodenectomy in Treatment Periampullary Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vo Truong Quoc</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Medicine and Pharmacy at Ho Chi Minh City</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This multi-site study will be done across Hepatobiliary and Pancreatic Surgery Department at&#xD;
      Cho Ray Hospital and University and Pharmacy Center. Patients who are diagnosed with&#xD;
      periampullary cancer from August 2021 to August 2023 will be underwent&#xD;
      pancreaticoduodenectomy. We will follow-up for their pancreatic fistula and bleeding&#xD;
      complication and analysis some risk factors.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigator will conduct this study at both site at the same time: Cho Ray Hospital and&#xD;
      University and Pharmacy Center. The investigator will directly consult the patient to&#xD;
      participate in the study, collect the preoperative information, intraoperative protocol and&#xD;
      postoperative data. The investigator will statically analysis the incident of the morbidity&#xD;
      (mainly for pancreatic fistula and bleeding), and invest some risk factors relating to those&#xD;
      complications.&#xD;
&#xD;
      Plan for conducting the study:&#xD;
&#xD;
        -  The patient diagnosed with periampullary cancer will be consulted with surgical method,&#xD;
           operative risks, postoperative complications and agree to participate in the study. The&#xD;
           patient signes a consent form to participate in the study.&#xD;
&#xD;
        -  Pancreaticoduodenectomy will be performed according to the uniformity protocol of both&#xD;
           hospitals: Cho Ray Hospital and University of Medicine and Pharmacy Center.&#xD;
&#xD;
        -  Post-operative data will be collected and based on the general procedure.&#xD;
&#xD;
      Data analysis&#xD;
&#xD;
        -  To determine the incidence of pancreatic fistula and bleeding, survival analysis will be&#xD;
           used.&#xD;
&#xD;
        -  To determine the association of risk factors with pancreatic fistula and bleeding,&#xD;
           logistic regression was used, the value with p &lt; 0.2 will be included in the&#xD;
           multivariable regression model to determine the real risk factors.&#xD;
&#xD;
      Sample size:&#xD;
&#xD;
      • The investigator expect approximately 100 patients in the first year in both centers. And&#xD;
      the investigator hope at least 150 patients in the whole conducting time.&#xD;
&#xD;
      Plan for missing data:&#xD;
&#xD;
      • The investigator will directly collect the patient information before the operation,&#xD;
      observe the operation process and follow-up the postoperative during. Investigator will&#xD;
      remove any case that missing preoperative information, operative data or post-operative&#xD;
      laboratory test.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 18, 2021</start_date>
  <completion_date type="Anticipated">August 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2023</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>30 Days</target_duration>
  <primary_outcome>
    <measure>Pancreatic fistula</measure>
    <time_frame>30 post-operative days</time_frame>
    <description>Rate of post-operative pancreatic fistula, risk factors associate to pancreatic fistula</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bleeding complication</measure>
    <time_frame>30 post-operative days</time_frame>
    <description>Rate and location of post-operative bleeding, risk factors relate to this complication</description>
  </secondary_outcome>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Periampullary Cancer</condition>
  <condition>Pancreatic Fistula</condition>
  <condition>Bleeding</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pancreaticoduodenectomy</intervention_name>
    <description>Patient with periampullary cancer will be underwent pancreaticoduodenectomy in 2 types of pancreatic-jejunal anastomosis reconstructions. We describe the postoperative complications (pancreatic fistula and bleeding) and analysis the risk factors relate to those complications</description>
    <other_name>Medical treatment after operation</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients diagnosed with periampullary cancer will be underwent pancreaticoduodenectomy and&#xD;
        will be followed-up after operation.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients diagnosed with periampullary cancer meet the following criteria:&#xD;
&#xD;
               -  Possibility to perform pancreaticoduodenectomy based on preoperative imaging and&#xD;
                  intraoperative exploration.&#xD;
&#xD;
               -  The postoperative pathology is adenocarcinoma (of the ampulla of Vater, common&#xD;
                  bile duct, duodenum or pancreas)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The patient has other organ's cancer beyond periampullary cancer.&#xD;
&#xD;
          -  Patient's medical conditions contraindicate for anesthesia.&#xD;
&#xD;
          -  The patient does not consent to participate in the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>TruongQuoc Vo, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Medicine and Pharmacy at HoChiMinh City</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>TruongQuoc Vo, Doctor</last_name>
    <phone>084364662378</phone>
    <email>bsvotruongquoc@ump.edu.vn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Phan Minh Tri</name>
      <address>
        <city>Ho Chi Minh City</city>
        <zip>700000</zip>
        <country>Vietnam</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Phan Minh Tri, Doctor</last_name>
      <phone>84944157733</phone>
      <email>phanminhtri2000@ump.edu.vn</email>
    </contact>
  </location>
  <location_countries>
    <country>Vietnam</country>
  </location_countries>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/32161987/</url>
    <description>Guidelines for Perioperative Care for Pancreaticoduodenectomy</description>
  </link>
  <results_reference>
    <citation>Melloul E, Lassen K, Roulin D, Grass F, Perinel J, Adham M, Wellge EB, Kunzler F, Besselink MG, Asbun H, Scott MJ, Dejong CHC, Vrochides D, Aloia T, Izbicki JR, Demartines N. Guidelines for Perioperative Care for Pancreatoduodenectomy: Enhanced Recovery After Surgery (ERAS) Recommendations 2019. World J Surg. 2020 Jul;44(7):2056-2084. doi: 10.1007/s00268-020-05462-w.</citation>
    <PMID>32161987</PMID>
  </results_reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 26, 2021</study_first_submitted>
  <study_first_submitted_qc>July 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 2, 2021</study_first_posted>
  <last_update_submitted>August 18, 2021</last_update_submitted>
  <last_update_submitted_qc>August 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Medicine and Pharmacy at Ho Chi Minh City</investigator_affiliation>
    <investigator_full_name>Vo Truong Quoc</investigator_full_name>
    <investigator_title>General Surgery Department, Principal Investigator, Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>Pancreatic Surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Fistula</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Fistula</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The IPD will be saved as a excel and spss file (with a password to open). This data can be shared with other researchers if needed.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

